These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9632844)

  • 1. Stimulation of bone formation in vivo by insulin-like growth factor-II in rats.
    Ishibe M; Ishibashi T; Kaneda K; Koda T; Rosier RN; Puzas JE
    Calcif Tissue Int; 1998 Jul; 63(1):36-8. PubMed ID: 9632844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis.
    Conover CA; Johnstone EW; Turner RT; Evans GL; John Ballard FJ; Doran PM; Khosla S
    Growth Horm IGF Res; 2002 Jun; 12(3):178-83. PubMed ID: 12162999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density.
    Rosen HN; Chen V; Cittadini A; Greenspan SL; Douglas PS; Moses AC; Beamer WG
    J Bone Miner Res; 1995 Sep; 10(9):1352-8. PubMed ID: 7502707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats.
    Machwate M; Zerath E; Holy X; Pastoureau P; Marie PJ
    Endocrinology; 1994 Mar; 134(3):1031-8. PubMed ID: 8119139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological study of recombinant human transforming growth factor beta 1-induced intramembranous ossification in neonatal rat parietal bone.
    Tanaka T; Taniguchi Y; Gotoh K; Satoh R; Inazu M; Ozawa H
    Bone; 1993; 14(2):117-23. PubMed ID: 8334028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats.
    Freitas FR; Capelo LP; O'Shea PJ; Jorgetti V; Moriscot AS; Scanlan TS; Williams GR; Zorn TM; Gouveia CH
    J Bone Miner Res; 2005 Feb; 20(2):294-304. PubMed ID: 15647824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats.
    Spencer EM; Liu CC; Si EC; Howard GA
    Bone; 1991; 12(1):21-6. PubMed ID: 2054232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of local injection of activin A on bone formation in newborn rats.
    Oue Y; Kanatani H; Kiyoki M; Eto Y; Ogata E; Matsumoto T
    Bone; 1994; 15(3):361-6. PubMed ID: 8068459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.
    Miyakoshi N; Qin X; Kasukawa Y; Richman C; Srivastava AK; Baylink DJ; Mohan S
    Endocrinology; 2001 Jun; 142(6):2641-8. PubMed ID: 11356715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone.
    Shinar DM; Endo N; Halperin D; Rodan GA; Weinreb M
    Endocrinology; 1993 Mar; 132(3):1158-67. PubMed ID: 8440176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors.
    Gabbitas B; Pash J; Canalis E
    Endocrinology; 1994 Jul; 135(1):284-9. PubMed ID: 8013362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graded doses of recombinant interleukin-1beta induce generalized osteopenia in rats without altering skeletal growth and joint integrity.
    del Pozo E; Popp AW; MacKenzie A; Perrelet R; Lamberts SW; Lippuner K
    Horm Res; 2005; 64(2):88-95. PubMed ID: 16155378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats.
    Vanderschueren D; van Herck E; Nijs J; Ederveen AG; De Coster R; Bouillon R
    Endocrinology; 1997 Jun; 138(6):2301-7. PubMed ID: 9165015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F; Lang K; Dony C; Kling L
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.
    Pfeilschifter J; Laukhuf F; Müller-Beckmann B; Blum WF; Pfister T; Ziegler R
    J Clin Invest; 1995 Aug; 96(2):767-74. PubMed ID: 7635970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of insulin on in vitro bone formation in fetal rat parietal bone.
    Yano H; Ohya K; Amagasa T
    Endocr J; 1994 Jun; 41(3):293-300. PubMed ID: 7951582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal bone growth in vitro: effects of insulin-like growth factor I and growth hormone.
    Scheven BA; Hamilton NJ
    Acta Endocrinol (Copenh); 1991 May; 124(5):602-7. PubMed ID: 2028719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.
    Mohan S; Richman C; Guo R; Amaar Y; Donahue LR; Wergedal J; Baylink DJ
    Endocrinology; 2003 Mar; 144(3):929-36. PubMed ID: 12586770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.